BeOne Medicines (ONC) said Wednesday the US Food and Drug Administration has granted accelerated approval to Beqalzi for the treatment of adults with relapsed or refractory mantle cell lymphoma, after at least two lines of systemic therapy.
The company said continued approval for this indication is contingent upon confirmation of clinical benefit in the confirmatory trial, which is underway.
Price: $317.94, Change: $+2.87, Percent Change: +0.91%
e.l.f. Beauty (ELF) could face a "tricky quarter" ahead of its fiscal Q4 results next week, with investors likely to focus more on the company's outlook than quarterly performance, UBS said in a note emailed Wednesday.The brokerage said that "much of the focus will center on initial FY27 guidance rather than the quarter itself," adding that investors are concerned if the company can perform and "provide an outlook that appears more than achievable without causing concern on the top line trajectory given tougher comps on the horizon."UBS said quarterly results are likely to be broadly in line with Wall Street expectations, while strong performance from rhode could provide some support to revenue growth.UBS expects fiscal 2027 guidance to be conservative, citing "challenging consumer backdrop."UBS maintained a neutral rating with a $70 price target.Price: $53.77, Change: $-1.89, Percent Change: -3.40%
(Updates with the latest stock movement in the first paragraph and headline.)TTEC (TTEC) shares were up over 8% in Wednesday trading after its digital unit struck a strategic deal with Amazon Web Services to accelerate Amazon Connect adoption.TTEC Digital will help organizations move beyond basic cloud migration to leverage AI, automation, and real-time data within Amazon Connect, the company said.The collaboration will provide tools for agent assistance, self-service and updating outdated contact center technology, it said.Price: $2.65, Change: $+0.21, Percent Change: +8.61%
Microsoft (MSFT) has spent over $100 billion on its partnership with OpenAI, including investments, infrastructure and cloud-computing costs, Microsoft executive Michael Wetter testified Monday in federal court, Bloomberg reported Wednesday."We needed to build Azure infrastructure in advance of providing those services to OpenAI," Wetter testified in federal court in Oakland, California, according to the report.Wetter appeared as part of a high-profile lawsuit brought by Elon Musk against OpenAI and Microsoft, according to the report. In the 2024 lawsuit, Musk accused OpenAI co-founders Sam Altman and Greg Brockman of abandoning the startup's original nonprofit mission by transitioning toward a for-profit structure. Musk also alleged Microsoft aided that shift, the report said.OpenAI, Altman, Brockman and Microsoft have denied wrongdoing and described Musk's claims as baseless harassment intended to benefit his AI startup, xAI, which launched in 2023, Bloomberg said.Microsoft and OpenAI didn't immediately reply to requests for comment from.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)Price: $405.11, Change: $-2.66, Percent Change: -0.65%